LncRNA CRNDE not only stimulates ovarian cancer progression by sponging miR-423-5p to upregulate FSCN1 expression [41], but also activates the miR-183/CCNB1 axis as an oncogene [42]. This evidence concerns the gene FSCN1 and ovarian carcinoma.